IL11 and cancer: LKB1 is an established tumour suppressor and IL11-mediated inactivation of LKB1, through its sequential phosphorylation at S325A (ERK) and S428A (P90RSK), leads to AMPK inactivation and mTOR activation [73], this sequence of events is linked with cancer cell proliferation [81].